Short-term interleukin-37 treatment improves vascular endothelial function, endurance exercise capacity, and whole-body glucose metabolism in old mice.

Aging Cell · 2020 · PMC6974720 · PMID 31755162

Europe PMC DOI

hedged sentence

0.0900

closest p · 1.8× alpha

0.0900

boldest claim

The sentences

a strong trendp = .09so close (0.05 < p ≤ 0.1)

We observed a strong trend toward a reduction in NADPHO p67 with IL‐37 compared with vehicle treatment ( p = .09; Figure 2 e).

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.